Baidu
map

肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

血液净化标准操作规程（2021版）

2021-11-09 中华人民共和国国家卫生健康委员会 医政医管局

血液透析

为进一步规范血液净化诊疗工作，适应血液净化技术的发展，保障医疗质量和安全，我委委托国家肾脏病医疗质量控制中心对《血液净化标准操作规程（2010版）》进行修订，形成了《血液净化标准操作规程（2021版）

中文标题：

血液净化标准操作规程（2021版）

发布机构：

中华人民共和国国家卫生健康委员会

发布日期：

2021-11-09

简要介绍：

为进一步规范血液净化诊疗工作，适应血液净化技术的发展，保障医疗质量和安全，国家卫生健康委委托国家肾脏病医疗质量控制中心对《血液净化标准操作规程（2010版）》进行修订，形成了《血液净化标准操作规程（2021版）》。

相关资料下载：
[AttachmentFileName(sort=1, fileName=血液净化标准操作规程2021.pdf)] GetToolGuiderByIdResponse(projectId=1, id=45c301c00225987c, title=血液净化标准操作规程（2021版）, enTitle=, guiderFrom=医政医管局, authorId=0, author=, summary=为进一步规范血液净化诊疗工作，适应血液净化技术的发展，保障医疗质量和安全，我委委托国家肾脏病医疗质量控制中心对《血液净化标准操作规程（2010版）》进行修订，形成了《血液净化标准操作规程（2021版）, cover=https://img.medsci.cn/20211110/1636553822555_1608702.jpg, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Tue Nov 09 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p style="color: #484848;"><span style="color: #484848;">为进一步规范血液净化诊疗工作，适应血液净化技术的发展，保障医疗质量和安全，国家卫生健康委委托国家肾脏病医疗质量控制中心对《血液净化标准操作规程（</span><span style="color: #484848;">2010版</span><span style="color: #484848;">）》进行修订，形成了《血液净化标准操作规程（</span><span style="color: #484848;">2021版</span><span style="color: #484848;"><span style="color: #484848; font-family: CESI仿宋-GB2312;">）》。</span></span></p>, tagList=[TagDto(tagId=2080, tagName=血液透析)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2080, guiderKeyword=血液透析, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=20944, appHits=364, showAppHits=0, pcHits=2354, showPcHits=20578, likes=5, shares=36, comments=21, approvalStatus=1, publishedTime=Tue Nov 16 23:57:33 CST 2021, publishedTimeString=2021-11-09, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Nov 10 23:18:20 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 22:37:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=血液净化标准操作规程2021.pdf)])
血液净化标准操作规程2021.pdf
下载请点击：
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2115072, encodeId=6de321150e249, content=标准 感谢梅斯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d43f8520729, createdName=ms9000000306115334, createdTime=Fri Feb 17 11:17:13 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206953, encodeId=95531206953eb, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=016c5557290, createdName=水水在学习, createdTime=Tue Mar 29 16:43:34 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204604, encodeId=1edb120460420, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3465525875, createdName=ms4000000334856878, createdTime=Mon Mar 21 13:28:15 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203947, encodeId=dc81120394e23, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ff5314336, createdName=14894708m63暂无昵称, createdTime=Sat Mar 19 06:54:37 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203946, encodeId=18261203946bc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ff5314336, createdName=14894708m63暂无昵称, createdTime=Sat Mar 19 06:54:27 CST 2022, time=2022-03-19, status=1, ipAttribution=)]
    2023-02-17 ms9000000306115334 来自江苏省

    标准 感谢梅斯

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2115072, encodeId=6de321150e249, content=标准 感谢梅斯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d43f8520729, createdName=ms9000000306115334, createdTime=Fri Feb 17 11:17:13 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206953, encodeId=95531206953eb, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=016c5557290, createdName=水水在学习, createdTime=Tue Mar 29 16:43:34 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204604, encodeId=1edb120460420, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3465525875, createdName=ms4000000334856878, createdTime=Mon Mar 21 13:28:15 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203947, encodeId=dc81120394e23, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ff5314336, createdName=14894708m63暂无昵称, createdTime=Sat Mar 19 06:54:37 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203946, encodeId=18261203946bc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ff5314336, createdName=14894708m63暂无昵称, createdTime=Sat Mar 19 06:54:27 CST 2022, time=2022-03-19, status=1, ipAttribution=)]
    2022-03-29 水水在学习

    值得学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2115072, encodeId=6de321150e249, content=标准 感谢梅斯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d43f8520729, createdName=ms9000000306115334, createdTime=Fri Feb 17 11:17:13 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206953, encodeId=95531206953eb, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=016c5557290, createdName=水水在学习, createdTime=Tue Mar 29 16:43:34 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204604, encodeId=1edb120460420, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3465525875, createdName=ms4000000334856878, createdTime=Mon Mar 21 13:28:15 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203947, encodeId=dc81120394e23, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ff5314336, createdName=14894708m63暂无昵称, createdTime=Sat Mar 19 06:54:37 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203946, encodeId=18261203946bc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ff5314336, createdName=14894708m63暂无昵称, createdTime=Sat Mar 19 06:54:27 CST 2022, time=2022-03-19, status=1, ipAttribution=)]
    2022-03-21 ms4000000334856878

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2115072, encodeId=6de321150e249, content=标准 感谢梅斯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d43f8520729, createdName=ms9000000306115334, createdTime=Fri Feb 17 11:17:13 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206953, encodeId=95531206953eb, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=016c5557290, createdName=水水在学习, createdTime=Tue Mar 29 16:43:34 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204604, encodeId=1edb120460420, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3465525875, createdName=ms4000000334856878, createdTime=Mon Mar 21 13:28:15 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203947, encodeId=dc81120394e23, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ff5314336, createdName=14894708m63暂无昵称, createdTime=Sat Mar 19 06:54:37 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203946, encodeId=18261203946bc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ff5314336, createdName=14894708m63暂无昵称, createdTime=Sat Mar 19 06:54:27 CST 2022, time=2022-03-19, status=1, ipAttribution=)]
    2022-03-19 14894708m63暂无昵称

    好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2115072, encodeId=6de321150e249, content=标准 感谢梅斯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d43f8520729, createdName=ms9000000306115334, createdTime=Fri Feb 17 11:17:13 CST 2023, time=2023-02-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206953, encodeId=95531206953eb, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=016c5557290, createdName=水水在学习, createdTime=Tue Mar 29 16:43:34 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204604, encodeId=1edb120460420, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3465525875, createdName=ms4000000334856878, createdTime=Mon Mar 21 13:28:15 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203947, encodeId=dc81120394e23, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ff5314336, createdName=14894708m63暂无昵称, createdTime=Sat Mar 19 06:54:37 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203946, encodeId=18261203946bc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ff5314336, createdName=14894708m63暂无昵称, createdTime=Sat Mar 19 06:54:27 CST 2022, time=2022-03-19, status=1, ipAttribution=)]
    2022-03-19 14894708m63暂无昵称

    好

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

血液灌流在维持性血液透析患者中的临床应用上海专家共识

上海市医学会(ShangHai Medical Association) · 2021-09-30

2019 ERBP临床实践指南：成人血液透析患者动静脉瘘和移植物围术期和术后护理

欧洲肾脏最佳临床实践(ERBP,European Renal Best Practice) · 2019-06-01

2019 AIOM/SIN共识意见：慢性肾病或血液透析的癌症患者的靶向治疗管理

意大利肿瘤医学协会(AIOM,Italian Association of Medical Oncology) · 2019-05-31

2019 香港肾脏服务临床实践指南：血液透析

香港医学相关专家组（统称） · 2019-03-02

2019 ESPN共识：需要维持性血液透析儿童患者的血管通路

欧洲儿科肾脏病学会(ESPU,European Society for Paediatric Nephrology) · 2019-03-11

2018 KHA-CARI指南：血液透析中心感染控制建议

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2018-10-16

拓展阅读

血液透析室建设与管理指南

暂未更新 · 2016-04-20

2012 JSDT指南：糖尿病患者血液透析

暂未更新 · 2012-03-19

2017 NICE诊断指南：多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理（DG.29）

暂未更新 · 2017-06-21

2017 KSN临床实践指南：中东呼吸综合征血液透析治疗

韩国肾脏病学会(KSN,Korean Society of Nephrology) · 2017-06-01

2017 ISRNM共识声明：血液透析治疗期间饮食

国际肾营养和代谢学会(ISRNM,International Society of Renal Nutrition and Metabolism) · 2017-12-20

2017年ISRNM《血液透析治疗期间饮食》专家共识解读

暂未更新 · 2018-07-20

Baidu
map
Baidu
map
Baidu
map